Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS

Lokman Hekim maintains a debt-to-equity ratio of 0.6, indicating a moderate reliance on debt financing, while its current ratio of 0.77 suggests potential liquidity constraints, as current assets fall short of current liabilities. The company's liquidity position is assessed as medium risk, with net cash being negative after subtracting total debt. Free cash flow is negative at -414.2 million TRY, driven by capital expenditures of -953.9 million TRY, which outpace operating cash flow of 217.6 million TRY. Profitability metrics show a return on equity (ROE) of 6.35% and a return on assets (ROA) of 2.59%, both below the typical thresholds for high-performing healthcare firms. Gross profit of 749.95 million TRY and operating income of 525.69 million TRY indicate a relatively narrow margin structure, with net income of 150.34 million TRY representing a 3.55% margin on total revenue. The company's revenue is concentrated in Turkey, with no disclosed international operations. Segment-wise, it operates two hospitals, but no further breakdown of revenue by service line or geographic region is available in the input data. This lack of diversification may expose the company to regional economic or regulatory risks. Revenue growth is not explicitly forecasted in the input data, but the company's capital expenditures suggest ongoing investment in infrastructure. The negative free cash flow indicates that the company is currently reinvesting rather than generating surplus cash for distribution or debt reduction. Risk factors include medium liquidity risk and a negative net cash position, which could constrain operational flexibility. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. No recent filings or transcripts are provided in the input data to inform recent strategic or operational developments.